alt

Giuseppe Lippi

Giuseppe Lippi

Giuseppe Lippi has a degree in Medicine and specialization in Clinical Biochemistry and Laboratory Medicine. He serves as Full Professor of Clinical Biochemistry and Molecular Biology at the University of Verona (Italy), Director Laboratory Service of the University Hospital of Verona (Italy) and Dean of the Faculty of Medicine at University of Verona. He has published 2140 articles in peer-reviewed journals, his total Impact Factor is over 13000 and the H-index is 130. Has participated to over 600 national and international congresses and has given more over 350 lectures to national and international meetings. He chairs the IFCC Task Force on COVID-19 and the EFLM Task Force Preparation of Labs for Emergencies. He has been awarded with the 2014 AACC Management Sciences and Patient Safety Division Award for outstanding contributions in the field of patient safety, the 2015 AACC Outstanding Speaker Award and the 2023 EFLM Award for Scientific Achievements in Laboratory Medicine. He has also received research grants from the EC and from Italian Heath Care Agencies. Giuseppe Lippi is Editor in Chief of “Annals of Translational Medicine” and “Journal of Laboratory and Precision Medicine” and also serves as Associate Editor of the journals “Clinical Chemistry and Laboratory Medicine”, “Seminars in Thrombosis and Hemostasis” and “Diagnosis”, is member of the European Federation of Laboratory Medicine (EFLM) Working Group on Preanalytical Variability (WG-PRE). The main fields of research include COVID-19, analytical and clinical validation of phenotypic and molecular biomarkers, diagnostics of thrombotic and hemorrhagic disorders and relevant assay methods, pre-analytical variability.